Review
Published on 26 Jan 2023
The role of transplantation in Hodgkin lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1054314
- 6,020 views
- 6 citations
Type at least 3 characters
1,748 articles
Articles
Brief Research Report
Published on 25 Jan 2023
Phenotypic plasticity of malignant T cells in blood and skin of a SĂ©zary syndrome patient revealed by single cell transcriptomics
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1090592
- 3,089 views
- 2 citations
Review
Published on 25 Jan 2023
The mesenchymal compartment in myelodysplastic syndrome: Its role in the pathogenesis of the disorder and its therapeutic targeting
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1102495
- 2,504 views
- 1 citation
Review
Published on 23 Jan 2023
Experts’ consensus on the definition and management of high risk multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1096852
- 10,152 views
- 20 citations
Systematic Review
Published on 20 Jan 2023
The prognostic value of tumor-associated macrophages detected by immunostaining in diffuse large B cell lymphoma: A meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1094400
- 2,419 views
- 8 citations
Editorial
Published on 20 Jan 2023
Editorial: Uncovering the relationship between myelodysplastic syndromes and acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1131785
- 1,002 views
Original Research
Published on 20 Jan 2023
Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty score
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1103687
- 1,898 views
- 1 citation
Case Report
Published on 20 Jan 2023
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1036455
- 4,846 views
- 7 citations
Perspective
Published on 19 Jan 2023
An alternative dosing strategy for ropeginterferon alfa-2b may help improve outcomes in myeloproliferative neoplasms: An overview of previous and ongoing studies with perspectives on the future
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1109866
- 7,032 views
- 17 citations
Original Research
Published on 19 Jan 2023
Real-world experiences of CNS-directed chemotherapy followed by autologous stem cell transplantation for secondary CNS involvement in relapsed or refractory diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1071281
- 2,470 views
- 1 citation
Case Report
Published on 19 Jan 2023
Case report: Hyperosmolar hyperglycemic syndrome secondary to PEG-asparaginase-induced hypertriglyceridemia and pancreatitis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1094964
- 1,981 views
- 1 citation
Case Report
Published on 18 Jan 2023
Case report: Successful management of a refractory double-expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1079890
- 2,690 views
- 1 citation
Review
Published on 18 Jan 2023
The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1105779
- 3,473 views
- 5 citations
Review
Published on 18 Jan 2023
The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1062524
- 23,838 views
- 17 citations
Original Research
Published on 16 Jan 2023
High-dose cytarabine monotherapy is superior to standard-dose cytarabine- based multiagent sequential treatment cycle for consolidation treatment in adult (14-59 years) AML patients according to European Leukemia Net 2022 risk stratification
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1070588
- 2,066 views
- 3 citations
Review
Published on 13 Jan 2023
Older patients with Hodgkin Lymphoma: Walking the tightrope of efficacy and toxicity
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1017787
- 8,373 views
- 3 citations